What is the address of Dr. Bart GYPEN?

The registered office of Dr. Bart GYPEN is located at Pulse pad 62, 2280 Grobbendonk.

Is Dr. Bart GYPEN still active?

Yes. According to the CBE (29 October 2026) Dr. Bart GYPEN is active, legal situation “Normale toestand”, started on 7 December 2010.

Is Dr. Bart GYPEN registered on Peppol?

Yes, Dr. Bart GYPEN is registered on the Peppol network with ID 0208:0831764607.

What is the enterprise number of Dr. Bart GYPEN?

The enterprise number of Dr. Bart GYPEN is BE0831764607.

When was Dr. Bart GYPEN founded?

Dr. Bart GYPEN was founded on 7 December 2010.

Who are the directors of Dr. Bart GYPEN?

According to the 2025 annual accounts, the directors of Dr. Bart GYPEN are: Bart Gypen.

Is Dr. Bart GYPEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 December 2010; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Bart GYPEN make in 2025?

Dr. Bart GYPEN posted a profit after taxes of € 138,962 in financial year 2025.

What is the revenue of Dr. Bart GYPEN?

As a small company, Dr. Bart GYPEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 228,624.

Dr. Bart GYPEN (Private Limited) - Grobbendonk

Dossier Dr. Bart GYPEN, printed on 29 October 2026 from databakkes.be/en/0831764607/dr-bart-gypen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Bart GYPEN from Grobbendonk, company number BE0831764607, closed financial year 2025 with a result of € 138,962 after tax. For that financial year Dr. Bart GYPEN recorded a gross margin of € 228,624 and equity of € 701,114. Compared with financial year 2024, the result moved from € 183,419 to € 138,962. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 701,114

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 138,962

▼ 24% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 446,289

▲ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 126,402 paid out

91 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 5,015

▲ € 4,361 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,756

▼ 34% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 50,568

▲ 55% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 183,018 Gross margin 2022: € 183,018 First fiscal year in the series	€ 192,480 Gross margin 2023: € 192,480 ▲ 5% vs 2022 (€ 183,018) Favourable step	€ 281,659 Gross margin 2024: € 281,659 ▲ 46% vs 2023 (€ 192,480) Favourable step	€ 228,624 Gross margin 2025: € 228,624 ▼ 19% vs 2024 (€ 281,659) Unfavourable step	▼ 19%
Profit after taxes	€ 119,075 Profit after taxes 2022: € 119,075 First fiscal year in the series	€ 123,155 Profit after taxes 2023: € 123,155 ▲ 3% vs 2022 (€ 119,075) Favourable step	€ 183,419 Profit after taxes 2024: € 183,419 ▲ 49% vs 2023 (€ 123,155) Favourable step	€ 138,962 Profit after taxes 2025: € 138,962 ▼ 24% vs 2024 (€ 183,419) Unfavourable step	▼ 24%
Equity	€ 636,173 Equity 2022: € 636,173 First fiscal year in the series	€ 672,528 Equity 2023: € 672,528 ▲ 6% vs 2022 (€ 636,173) Favourable step	€ 688,553 Equity 2024: € 688,553 ▲ 2% vs 2023 (€ 672,528) Favourable step	€ 701,114 Equity 2025: € 701,114 ▲ 2% vs 2024 (€ 688,553) Favourable step	▲ 2%
Total debts	€ 247,557 Total debts 2022: € 247,557 First fiscal year in the series	€ 309,608 Total debts 2023: € 309,608 ▲ 25% vs 2022 (€ 247,557) Unfavourable step	€ 89,152 Total debts 2024: € 89,152 ▼ 71% vs 2023 (€ 309,608) Favourable step	€ 220,692 Total debts 2025: € 220,692 ▲ 148% vs 2024 (€ 89,152) Unfavourable step	▲ 148%
Cash	€ 683,294 Cash 2022: € 683,294 First fiscal year in the series	€ 792,326 Cash 2023: € 792,326 ▲ 16% vs 2022 (€ 683,294) Favourable step	€ 285,590 Cash 2024: € 285,590 ▼ 64% vs 2023 (€ 792,326) Unfavourable step	€ 446,289 Cash 2025: € 446,289 ▲ 56% vs 2024 (€ 285,590) Favourable step	▲ 56%
Land & buildings	€ 120,711 Land & buildings 2022: € 120,711 First fiscal year in the series	€ 110,017 Land & buildings 2023: € 110,017 ▼ 9% vs 2022 (€ 120,711) Unchanged	€ 429,738 Land & buildings 2024: € 429,738 ▲ 291% vs 2023 (€ 110,017) Unchanged	€ 404,512 Land & buildings 2025: € 404,512 ▼ 6% vs 2024 (€ 429,738) Unchanged	▼ 6%
Retained profit	€ 617,573 Retained profit 2022: € 617,573 First fiscal year in the series	€ 653,928 Retained profit 2023: € 653,928 ▲ 6% vs 2022 (€ 617,573) Favourable step	€ 687,552 Retained profit 2024: € 687,552 ▲ 5% vs 2023 (€ 653,928) Favourable step	€ 700,113 Retained profit 2025: € 700,113 ▲ 2% vs 2024 (€ 687,552) Favourable step	▲ 2%
Dividend	€ 611,599 Dividend 2022: € 611,599 First fiscal year in the series	€ 86,799 Dividend 2023: € 86,799 ▼ 86% vs 2022 (€ 611,599) Unchanged	€ 149,795 Dividend 2024: € 149,795 ▲ 73% vs 2023 (€ 86,799) Unchanged	€ 126,402 Dividend 2025: € 126,402 ▼ 16% vs 2024 (€ 149,795) Unchanged	▼ 16%
Balance sheet total	€ 883,730 Balance sheet total 2022: € 883,730 First fiscal year in the series	€ 982,137 Balance sheet total 2023: € 982,137 ▲ 11% vs 2022 (€ 883,730) Unchanged	€ 777,706 Balance sheet total 2024: € 777,706 ▼ 21% vs 2023 (€ 982,137) Unchanged	€ 921,805 Balance sheet total 2025: € 921,805 ▲ 19% vs 2024 (€ 777,706) Unchanged	▲ 19%

Key figures of Dr. Bart GYPEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Bart GYPEN?

What happened at Dr. Bart GYPEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 138,962 (▼ 24% vs 2024). filed late Source: NBB ↗
Dec 7, 2010 New establishment in Grobbendonk. KBO
Dec 7, 2010 Start of the company according to the CBE. KBO

In short

From € 119,075 profit in 2022 to € 138,962 profit in 2025.

Paid € 246,708 in corporate taxes since 2022.

Best year ever: 2024, with € 183,419 profit.

Paid out € 974,595 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Bart Gypen

Dr. Bart GYPEN

ZAZINA

Behind Dr. Bart GYPEN is Bart Gypen. Bart Gypen is also behind ZAZINA.

Directors

According to the 2025 annual accounts

Bart Gypen

Director

Also active at: ZAZINA

Establishments

Establishment units

Physical locations of this company

Registered office

Pulse pad 62

2280 Grobbendonk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Associatie Algemene Chirurgen Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0831.764.607
VAT number: BE 0831.764.607
Registered office: Pulse pad 62, 2280 Grobbendonk
Names & denominations: Dr. Bart GYPEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 December 2010
Peppol: Active · Active since 20 Aug 2025

View on CBE Public ↗ Annual accounts (NBB) ↗